Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Pharmaceutical Design
|
June 2, 2015
Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Resham Chhabra, Giovanni Tosi, Andreas M Grabrucker
Journal of Neurochemistry
|
June 23, 2016
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice
Tasnuva Sarowar, Resham Chhabra, Antonietta Vilella, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
|
July 11, 2014
Loss of COMMD1 and copper overload disrupt zinc homeostasis and influence an autism-associated pathway at glutamatergic synapses
Tanja Baecker, Katharina Mangus, Stefanie Pfaender, et al.
Acta Neuropathologica
|
October 28, 2016
Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model
Katherine D LaClair, Aneesh Donde, Jonathan P Ling, et al.
Experimental Neurology
|
January 3, 2014
The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation
Stefanie Grabrucker, Christian Proepper, Katharina Mangus, et al.
Cell Reports
|
September 30, 2016
PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons
Jonathan P Ling, Resham Chhabra, Jonathan D Merran, et al.
International Journal of Pharmaceutics
|
June 3, 2014
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release
Resham Chhabra, Andreas M Grabrucker, Patrizia Veratti, et al.
Aging Cell
|
August 8, 2013
Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease
Joe Atherton, Ksenia Kurbatskaya, Marie Bondulich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 15, 2014
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport
Giovanni Tosi, Antonietta Vilella, Resham Chhabra, et al.
CNS & Neurological Disorders Drug Targets
|
August 22, 2015
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo
Resham Chhabra, Barbara Ruozi, Antonietta Vilella, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Pharmaceutical Design
|
June 2, 2015
Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Resham Chhabra, Giovanni Tosi, Andreas M Grabrucker
Journal of Neurochemistry
|
June 23, 2016
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice
Tasnuva Sarowar, Resham Chhabra, Antonietta Vilella, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
|
July 11, 2014
Loss of COMMD1 and copper overload disrupt zinc homeostasis and influence an autism-associated pathway at glutamatergic synapses
Tanja Baecker, Katharina Mangus, Stefanie Pfaender, et al.
Acta Neuropathologica
|
October 28, 2016
Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model
Katherine D LaClair, Aneesh Donde, Jonathan P Ling, et al.
Experimental Neurology
|
January 3, 2014
The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation
Stefanie Grabrucker, Christian Proepper, Katharina Mangus, et al.
Cell Reports
|
September 30, 2016
PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons
Jonathan P Ling, Resham Chhabra, Jonathan D Merran, et al.
International Journal of Pharmaceutics
|
June 3, 2014
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release
Resham Chhabra, Andreas M Grabrucker, Patrizia Veratti, et al.
Aging Cell
|
August 8, 2013
Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease
Joe Atherton, Ksenia Kurbatskaya, Marie Bondulich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 15, 2014
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport
Giovanni Tosi, Antonietta Vilella, Resham Chhabra, et al.
CNS & Neurological Disorders Drug Targets
|
August 22, 2015
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo
Resham Chhabra, Barbara Ruozi, Antonietta Vilella, et al.
Page
of 2